Skip to main content
TELCON RF PHARMACEUTICAL. Inc. logo

TELCON RF PHARMACEUTICAL. Inc. — Investor Relations & Filings

Ticker · 200230 ISIN · KR7200230001 KO Manufacturing
Filings indexed 352 across all filing types
Latest filing 2020-05-28 Board/Management Inform…
Country KR South Korea
Listing KO 200230

About TELCON RF PHARMACEUTICAL. Inc.

http://www.telcon-rf.com

TELCON RF PHARMACEUTICAL. Inc. operates across two primary business segments: radio frequency (RF) components and pharmaceuticals. The RF division specializes in the development, manufacturing, and global sale of components for wireless communication equipment. Its main products include RF coaxial connectors, cable assemblies, coaxial couplers, and distributors. The pharmaceutical and biotechnology division is engaged in the development and sale of medicinal products.

Recent filings

Filing Released Lang Actions
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a formal regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the appointment and resignation of outside directors (사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고). This type of disclosure specifically concerns changes in the composition of the board of directors, which falls under the 'Board/Management Information' category.
2020-05-28 Korean
분기보고서 (2020.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company '주식회사 텔콘알에프제약' covering the period from January 1, 2020, to March 31, 2020. It contains detailed corporate information, history, capital changes, and financial data, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2020
2020-05-15 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea (DART system) used when an entity's shareholding in a listed company crosses a specific threshold (typically 5%). This document details the identity of the shareholder (Emmaus Life Sciences Inc.), the target company (Telcon RF Pharmaceutical), the number of shares held, and the specific dates and prices of transactions (market sales). This falls under the category of Major Shareholding Notification.
2020-05-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service (증권선물위원회) and the Korea Exchange. It details changes in share ownership by a major shareholder (Emmaus Life Sciences Inc.) in Telcon RF Pharmaceutical. This type of filing is specifically categorized as a 'Director's Dealing' (DIRS) report in the provided schema, as it tracks insider/major shareholder transactions.
2020-05-08 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a formal 'Notice of Extraordinary General Meeting' (제22기 임시주주총회 소집통지서) issued by Telcon RF Pharmaceutical. It contains the meeting agenda, voting procedures, electronic voting instructions, and management reference materials (such as director activity reports and business overviews). This document is a standard proxy statement/notice sent to shareholders to inform them of an upcoming meeting and solicit their participation/votes. In the provided taxonomy, this fits best under 'Proxy Solicitation & Information Statement'.
2020-04-24 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Proxy Solicitation' (위임권유) filed by Telcon RF Pharmaceutical. It contains information regarding the solicitation of proxies for an upcoming Extraordinary General Meeting (EGM), including the purpose of the meeting, details of the solicitor, and financial statements (balance sheets, income statements) provided as reference materials for shareholders to make informed voting decisions. This aligns perfectly with the definition of a Proxy Solicitation & Information Statement.
2020-04-24 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.